Have a personal or library account? Click to login
Characteristics and Clinical Significance of Gut Microbiota in Patients with Invasive Pulmonary Aspergillosis Cover

Characteristics and Clinical Significance of Gut Microbiota in Patients with Invasive Pulmonary Aspergillosis

Open Access
|Jun 2025

References

  1. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013 Dec;504(7480):451–455. https://doi.org/10.1038/nature12726
  2. Aziz T, Hussain N, Hameed Z, Lin L. Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations. Gut Microbes. 2024 Jan– Dec;16(1):2297864. https://doi.org/10.1080/19490976.2023.2297864
  3. Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010 Jun;50(12):1559– 1567. https://doi.org/10.1086/652768
  4. Benítez-Páez A, Gómez Del Pugar EM, López-Almela I, Moya-Pérez Á, Codoñer-Franch P, Sanz Y. Depletion of Blautia species in the microbiota of obese children relates to intestinal inflammation and metabolic phenotype worsening. mSystems. 2020 Mar;5(2):e00857-19. https://doi.org/10.1128/mSystems.00857-19
  5. Bertelsen A, Elborn JS, Schock BC. Microbial interaction: Prevotella spp. reduce P. aeruginosa induced inflammation in cystic fibrosis bronchial epithelial cells. J Cyst Fibros. 2021 Jul;20(4):682–691. https://doi.org/10.1016/j.jcf.2021.04.012
  6. Caspi R, Billington R, Keseler IM, Kothari A, Krummenacker M, Midford PE, Ong WK, Paley S, Subhraveti P, Karp PD. The MetaCyc database of metabolic pathways and enzymes - a 2019 update. Nucleic Acids Res. 2020 Jan;48(D1):D445-D453. https://doi.org/10.1093/nar/gkz862
  7. Chen S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. Imeta. 2023 May;2(2):e107. https://doi.org/10.1002/imt2.107
  8. Chen Y, Chang SKC, Zhang Y, Hsu CY, Nannapaneni R. Gut microbiota and short chain fatty acid composition as affected by legume type and processing methods as assessed by simulated in vitro digestion assays. Food Chem. 2020 May;312:126040. https://doi.org/10.1016/j.foodchem.2019.126040
  9. Deng S, Yu T, Yu Z. [Ischemic preconditioning maintains myocardial mitochondria cardiolipin and attenuates heart impairment in isolated rat hearts] (in Chinese). J Army Med Univ. 2009;31(18):1736–1739. https://doi.org/10.16016/j.1000-5404.2009. 18.015
  10. Dillon SM, Lee EJ, Kotter CV, Austin GL, Dong Z, Hecht DK, Gianella S, Siewe B, Smith DM, Landay AL, et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 2014 Jul;7(4):983–994. https://doi.org/10.1038/mi.2013.116
  11. Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020 Sep;71(6):1367–1376. https://doi.org/10.1093/cid/ciz1008
  12. Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, Lipson KS, Knight R, Caporaso JG, Segata N, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018 Nov;15(11):962–968. https://doi.org/10.1038/s41592-018-0176-y
  13. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013 Dec;504(7480):446–450. https://doi. org/10.1038/nature12721
  14. Gao W, Howden BP, Stinear TP. Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen. Curr Opin Microbiol. 2018 Feb;41:76–82. https://doi.org/10.1016/j. mib.2017.11.030
  15. García-López M, Meier-Kolthoff JP, Tindall BJ, Gronow S, Woyke T, Kyrpides NC, Hahnke RL, Göker M. Analysis of 1,000 type-strain genomes improves taxonomic classification of Bacteroidetes. Front Microbiol. 2019 Sep;10:2083. https://doi.org/10.3389/fmicb.2019.02083
  16. Groves HT, Cuthbertson L, James P, Moffatt MF, Cox MJ, Tregoning JS. Respiratory disease following viral lung infection alters the murine gut microbiota. Front Immunol. 2018 Feb;9:182. https://doi.org/10.3389/fimmu.2018.00182
  17. Grünig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med. 1997 Mar;185(6):1089–1099. https://doi.org/10.1084/jem.185.6.1089
  18. He Q, Li M, Cao J, Zhang M, Feng C. Diagnosis values of Dectin-1 and IL-17 levels in plasma for invasive pulmonary aspergillosis in bronchiectasis. Front Cell Infect Microbiol. 2022 Oct;12:1018499. https://doi.org/10.3389/fcimb.2022.1018499
  19. Hebart H, Bollinger C, Fisch P, Sarfati J, Meisner C, Baur M, Loeffler J, Monod M, Latgé JP, Einsele H. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood. 2002 Dec;100(13):4521– 4528. https://doi.org/10.1182/blood-2002-01-0265
  20. Hérivaux A, Willis JR, Mercier T, Lagrou K, Gonçalves SM, Gonçales RA, Maertens J, Carvalho A, Gabaldón T, Cunha C. Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients. Thorax. 2022 Mar;77(3):283–291. https://doi.org/10.1136/thorax-jnl-2020-216179
  21. Hu X, Gong L, Zhou R, Han Z, Ji L, Zhang Y, Zhang S, Wu D. Variations in gut microbiome are associated with prognosis of hypertriglyceridemia-associated acute pancreatitis. Biomolecules. 2021 May;11(5):695. https://doi.org/10.3390/biom11050695
  22. Hu Y, Feng Y, Wu J, Liu F, Zhang Z, Hao Y, Liang S, Li B, Li J, Lv N, et al. The gut microbiome signatures discriminate healthy from pulmonary tuberculosis patients. Front Cell Infect Microbiol. 2019 Apr;9:90. https://doi.org/10.3389/fcimb.2019.00090
  23. Iljazovic A, Amend L, Galvez EJC, de Oliveira R, Strowig T. Modulation of inflammatory responses by gastrointestinal Prevotella spp. – From associations to functional studies. Int J Med Microbiol. 2021 Feb;311(2):151472. https://doi.org/10.1016/j.ijmm.2021.151472
  24. Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Núñez G, Shibuya A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe. 2014 Jan;15(1):95–102. https://doi.org/10.1016/j.chom.2013.12.010
  25. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015 Mar;70(3):270–277. https://doi.org/10.1136/thoraxjnl-2014-206291
  26. Kulas J, Mirkov I, Tucovic D, Zolotarevski L, Glamoclija J, Veljovic K, Tolinacki M, Golic N, Kataranovski M. Pulmonary Aspergillus fumigatus infection in rats affects gastrointestinal homeostasis. Immunobiology. 2019 Jan;224(1):116–123. https://doi.org/10.1016/j.imbio.2018.10.001
  27. Kusakabe T, Lin WY, Cheong JG, Singh G, Ravishankar A, Yeung ST, Mesko M, DeCelie MB, Carriche G, Zhao Z, et al. Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19. Nat Immunol. 2023 Nov;24(11):1879–1889. https://doi.org/10.1038/s41590-023-01637-4
  28. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25. https://doi.org/10.1186/gb-2009-10-3-r25
  29. Larsen JM, Steen-Jensen DB, Laursen JM, Søndergaard JN, Musavian HS, Butt TM, Brix S. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One. 2012;7(2):e31976. https://doi.org/10.1371/journal.pone.0031976
  30. Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug;151(4):363-374. https://doi.org/10.1111/imm.12760
  31. Machado MG, Sencio V, Trottein F. Short-chain fatty acids as a potential treatment for infections: a closer look at the lungs. Infect Immun. 2021 Aug;89(9):e0018821. https://doi.org/10.1128/iai.00188-21
  32. Mateos-Hernández L, Risco-Castillo V, Torres-Maravilla E, Ber-múdez-Humarán LG, Alberdi P, Hodžić A, Hernández-Jarguin A, Rakotobe S, Galon C, Devillers E, et al. Gut microbiota abrogates anti-α-Gal IgA response in lungs and protects against experimental Aspergillus infection in poultry. Vaccines. 2020 Jun;8(2):285. https://doi.org/10.3390/vaccines8020285
  33. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008 May;453(7195):620–625. https://doi.org/10.1038/nature07008
  34. Moutsoglou DM, Tatah J, Prisco SZ, Prins KW, Staley C, Lopez S, Blake M, Teigen L, Kazmirczak F, Weir EK, et al. Pulmonary arterial hypertension patients have a proinflammatory gut microbiome and altered circulating microbial metabolites. Am J Respir Crit Care Med. 2023 Mar;207(6):740–756. https://doi.org/10.1164/rccm.202203-0490OC
  35. Park S, Zhang T, Kang S. Fecal microbiota composition, their interactions, and metagenome function in US adults with type 2 diabetes according to enterotypes. Int J Mol Sci. 2023 May;24(11):9533. https://doi.org/10.3390/ijms24119533
  36. R Core Team. A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2023 [cited 2024 Nov 28]. Available from https://www.r-project.org
  37. Ren X, Gamallat Y, Liu D, Zhu Y, Meyiah A, Yan C, Shang D, Xin Y. The distribution characteristics of intestinal microbiota in children with community-acquired pneumonia under five years of age. Microb Pathog. 2020 Feb;142:104062. https://doi.org/10.1016/j.micpath.2020.104062
  38. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):605– 616. https://doi.org/10.1038/s41575-019-0173-3
  39. Scheffold A, Bacher P. Anti-fungal T cell responses in the lung and modulation by the gut-lung axis. Curr Opin Microbiol. 2020 Aug;56:67–73. https://doi.org/10.1016/j.mib.2020.06.006
  40. Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD, Hoogendijk AJ, de Beer R, de Vos A, Belzer C, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016 Apr;65(4):575–583. https://doi.org/10.1136/gutjnl-2015-309728
  41. Seo KW, Kim DH, Sohn SK, Lee NY, Chang HH, Kim SW, Jeon SB, Baek JH, Kim JG, Suh JS, et al. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant. 2005 Dec;36(12):1089–1095. https://doi.org/10.1038/sj.bmt.1705181
  42. Shen Y, Yu F, Zhang D, Zou Q, Xie M, Chen X, Yuan L, Lou B, Xie G, Wang R, et al. Dynamic alterations in the respiratory tract microbiota of patients with COVID-19 and its association with microbiota in the gut. Adv Sci. 2022 Sep;9(27):e2200956. https://doi.org/10.1002/advs.202200956
  43. Sungono V, Hariyanto H, Soesilo TEB, Adisasmita AC, Syarif S, Lukito AA, Widysanto A, Puspitasari V, Tampubolon OE, Sutrisna B, et al. Cohort study of the APACHE II score and mortality for different types of intensive care unit patients. Postgrad Med J. 2022 Dec;98(1166):914–918. https://doi.org/10.1136/postgrad-medj-2021-140376
  44. Villena J, Kitazawa H. The modulation of mucosal antiviral immunity by immunobiotics: Could they offer any benefit in the SARS-CoV-2 pandemic? Front Physiol. 2020 Jun 16;11:699. https://doi.org/10.3389/fphys.2020.00699
  45. Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, Edwards JR, Sievert DM. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016 Nov;37(11):1288–1301. https://doi.org/10.1017/ice.2016.174
  46. Wu T, Xu F, Su C, Li H, Lv N, Liu Y, Gao Y, Lan Y, Li J. Alterations in the gut microbiome and cecal metabolome during Klebsiella pneumoniae-induced pneumosepsis. Front Immunol. 2020 Jul;11:1331. https://doi.org/10.3389/fimmu.2020.01331
  47. Xu X, Zhang W, Guo M, Xiao C, Fu Z, Yu S, Jiang L, Wang S, Ling Y, Liu F, et al. Integrated analysis of gut microbiome and host immune responses in COVID-19. Front Med. 2022 Apr;16(2):263– 275. https://doi.org/10.1007/s11684-022-0921-6
  48. Yang L, Yang J, Zhang X, Ye X, Liu Y, Wei B, Wang J. Predictive value of soluble CD40L combined with APACHE II score in elderly patients with sepsis in the emergency department. BMC Anes-thesiol. 2024 Jan 19;24(1):32. https://doi.org/10.1186/s12871-023-02381-w
  49. Zafar H, Saier MH Jr. Gut Bacteroides species in health and disease. Gut Microbes. 2021 Jan–Dec;13(1):1–20. https://doi.org/10.1080/1 9490976.2020.1848158
  50. Zhang J, Deng J, Li J, Su Y, Hu J, Lin D, Su M, Chen Y, Liao S, Bai X, et al. Changes of gut microbiota under different nutritional methods in elderly patients with severe COVID-19 and their relationship with prognosis. Front Immunol. 2023 Sep;14:1260112. https://doi.org/10.3389/fimmu.2023.1260112
DOI: https://doi.org/10.33073/pjm-2025-011 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 131 - 142
Submitted on: Dec 18, 2024
Accepted on: Feb 15, 2025
Published on: Jun 9, 2025
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 JIAQI CAO, QIAN HE, MING ZHANG, RONG ZHOU, CHUNLAI FENG, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.